COVID-19 has been linked to an increased risk of Aspergillus infection. Aspergillus is a common mold that can cause a range of respiratory illnesses, including allergic reactions, asthma attacks, and even more serious infections of the lungs.
The risk of Aspergillus infection is greater for people with underlying health conditions, such as diabetes, HIV, and cancer, as well as people who are immunocompromised. People with chronic respiratory conditions such as asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD) are also at higher risk for Aspergillus infection.
It is believed that COVID-19 increases the risk of Aspergillus infection by weakening the immune system and making it more vulnerable to infection. In addition, many of the treatments used to treat COVID-19, such as corticosteroids and immunosuppressive drugs, can further weaken the immune system and increase the risk of Aspergillus infection.
The symptoms of Aspergillus infection can vary, depending on the severity of the infection. Common symptoms include fever, coughing, wheezing, chest pain, and shortness of breath. In more severe cases, it can cause pneumonia and can even spread to other parts of the body, such as the brain and other organs.
If you are at risk for Aspergillus infection, it is important to take steps to reduce your risk. This includes avoiding contact with people who have respiratory illnesses, avoiding areas with high levels of mold and dust, and taking steps to reduce exposure to environmental pollutants. If you have an underlying health condition, it is important to talk to your doctor about your risk for Aspergillus infection and to make sure you are up to date on any necessary vaccinations.